A new 456-page report projects the global women's clinical trials and CRO market will grow from $9.9 billion in 2026 to $22.3 billion by 2036, as biomarker-driven research and decentralized trial models transform how women's health studies are designed and ru… For the full story, visit the source.
Business
Women's Clinical Trials & CROs Market Forecast to More Than Double by 2036 as Precision Medicine Reshapes Trial Design
A new 456-page report projects the global women's clinical trials and CRO market will grow from $9.9 billion in 2026 to $22.3 billion by 2036, as biomarker-driven research and decentralized trial models transform how women's health studies are designed and ru…
By Research and Markets· GlobeNewswire· 3 months ago· 2 min read
This summary is sourced from GlobeNewswire. Read the full article at:GlobeNewswire